Ignite Creation Date:
2024-05-06 @ 9:18 AM
Last Modification Date:
2024-10-26 @ 12:13 PM
Study NCT ID:
NCT02955290
Status:
RECRUITING
Last Update Posted:
2023-11-08
First Post:
2016-11-02
Brief Title:
CIMAvax Vaccine Nivolumab and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer
Sponsor:
Roswell Park Cancer Institute
Organization:
Roswell Park Cancer Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12-22
Start Date Type:
ACTUAL
Primary Completion Date:
2027-12-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12-09
Completion Date Type:
ESTIMATED
First Submit Date:
2016-11-02
First Submit QC Date:
November 2 2016
Study First Post Date:
2016-11-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-22
Last Update Post Date:
2023-11-08
Last Update Post Date Type:
ACTUAL